JFL Life Sciences Ltd
JFLLIFEJFL Life Sciences Ltd
JFLLIFE
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 2.61 | 0.30% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
JFL Life Sciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing of pharmaceutical products
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31.78 | 30.20 | 32.86 | 34.48 | 44.47 | 47.07 | — | |||||||
Raw Materials | 28.81 | 26.72 | 28.76 | 30.49 | 33.26 | 38.23 | — | |||||||
| Power & Fuel Cost | 0.18 | 0.30 | 0.19 | 0.30 | 0.34 | 0.48 | ||||||||
| Employee Cost | 0.96 | 1.25 | 0.98 | 1.43 | 1.83 | 2.01 | ||||||||
| Selling & Administrative Expenses | 0.13 | 0.16 | 0.29 | 0.56 | 0.63 | 0.46 | ||||||||
| Operating & Other expenses | 0.38 | -0.13 | 0.39 | -4.55 | 2.84 | 0.82 | ||||||||
EBITDA | 1.32 | 1.90 | 2.25 | 6.25 | 5.57 | 5.07 | — | |||||||
| Depreciation/Amortization | 0.15 | 0.24 | 0.28 | 0.37 | 0.43 | 0.44 | — | |||||||
| PBIT | 1.17 | 1.66 | 1.97 | 5.88 | 5.14 | 4.63 | — | |||||||
| Interest & Other Items | 0.75 | 1.16 | 1.23 | 2.08 | 1.42 | 0.83 | — | |||||||
| PBT | 0.42 | 0.50 | 0.74 | 3.80 | 3.72 | 3.80 | — | |||||||
| Taxes & Other Items | 0.12 | 0.14 | 0.20 | 0.99 | 0.91 | 0.50 | — | |||||||
| Net Income | 0.30 | 0.36 | 0.54 | 2.81 | 2.81 | 3.30 | — | |||||||
| EPS | 0.06 | 0.07 | 0.10 | 0.43 | 0.53 | 1.00 | — | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| JFL Life Sciences Ltd | 28.15 | 2.61 | 0.30% |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare JFLLIFE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Dec 2022
Mar 2023
Sep 2023
Mar 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹0.25
Ex DateEx Date
Sep 13, 2024
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 31 August 2024.Powered by Capital Market - Live
JFL Life Sciences announced that the Board of Directors of the Company at its meeting held on 2 August 2024, inter alia, have recommended the final dividend of Rs 0.25 per equity Share (i.e. 2.5%) , subject to the approval of the shareholders.Powered by Capital Market - Live
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 2 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 8.17%, vs industry avg of 9.03%
Constant Market Share
Over the last 5 years, market share stayed at 0.01%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 61.54%, vs industry avg of 15.28%